News Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Delayed London S.E. Other stock markets 06:26:30 2024-05-17 am EDT			5-day change	1st Jan Change
12.88 ^GBX	+0.62%		-6.33%	+42.32%

May. 01	Poolbeg Pharma Secures Full Patent in US for Immunomodulator II	MT
May. 01	Poolbeg Pharma celebrates full patent approval for Immunomodulator II	AN

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poolbeg Pharma plc - Annual Report and AGM Notice	May. 10	AQ
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office	May. 08	AQ
Poolbeg Pharma Secures Full Patent in US for Immunomodulator II	May. 01	MT
Poolbeg Pharma celebrates full patent approval for Immunomodulator II	May. 01	AN
Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug	May. 01	AQ
Poolbeg Pharma plc - Appointment of Joint Broker	May. 01	AQ
Poolbeg Pharma PLC Receives the Fully Granted Patent from the U.S. Patent Office for Its Immunomodulator II Patent Application	May. 01	CI
Poolbeg Pharma Signs Option Deal to Buy Orphan Drug Candidate from Silk Road Therapeutics	Apr. 30	MT
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	Apr. 30	AN
Earnings Flash (POLB.L) POOLBEG PHARMA Posts FY23 Loss GBX-0.79	Apr. 30	MT
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	Mar. 20	AN
Poolbeg Pharma plc Announces POLB 001 US Patent Update	Mar. 20	CI
Poolbeg Pharma plc - Director Share Purchase	Feb. 23	AQ
Poolbeg Pharma plc - Director Share Purchase	Feb. 20	AQ
Poolbeg Pharma chair discusses shift to executive role; hVIVO share sale	Feb. 20	AQ
Diversified Energy offers dividend alternative	Feb. 15	AN
Poolbeg Pharma's Nonexecutive Chair Transitions to Executive Role	Feb. 15	MT
Poolbeg Pharma plc Appoints Cathal Friel as Executive Chairman	Feb. 15	CI
Katoro Gold launches fundraising, eyes board shake-up	Feb. 12	AN
Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies	Feb. 12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Summary

Filters